<DOC>
	<DOCNO>NCT00490399</DOCNO>
	<brief_summary>The purpose study evaluate efficacy gemcitabine cisplatin Korean patient biliary tract ( bile tract gallbladder liver ) cancer .</brief_summary>
	<brief_title>Trial Gemcitabine Cisplatin Patients With Inoperable Biliary Tract Carcinomas</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Histologic cytologic diagnosis adenocarcinoma gallbladder , intra/extrahepatic bile duct papilla Vater locally advance metastatic disease ( study entry ) amenable curative surgical resection recurrent disease prior surgical resection radiotherapy . Disease status must measurable disease define : Bidimensionally measurable lesion clearly define margin two perpendicular diameter clearly measurable following : Computerized tomography ( CT ) magnetic resonance imaging ( MRI ) , one diameter 2.0 cm great diameter 1.0 cm great . Palpable Lesion , diameter 2 cm great . Disease progress area prior radiation therapy may include . Patients must receive prior chemotherapy advance disease . Prior radiotherapy must complete least 4 week study enrollment . Patients must recover acute toxic effect treatment prior study enrollment . Treatment within last 30 day drug receive regulatory approval indication time study entry . Heart failure , angina pectoris arrhythmia poorly control spite medication acute myocardial infarction within 6 month precede study enrollment Severe neurological mental disorder . Active infection opinion investigator would compromise patient â€™ ability tolerate therapy . Poorly control diabetes mellitus .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2007</verification_date>
</DOC>